Literature DB >> 15958578

Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells.

Costas G Hadjipanayis1, Neal A DeLuca.   

Abstract

Expression of the herpes simplex virus (HSV) protein, ICP0, from the viral genome, rendered two radioresistant human glioblastoma multiforme cell lines more sensitive to the effects of ionizing radiation. Using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and clonogenic survival assays, U87-MG and T98 cell survival was more greatly decreased as a function of ionizing radiation dose when ICP0 was preexpressed in cells compared with when ICP0 was not expressed. Consistent with previous results, we found that the catalytic subunit of DNA-dependent protein kinase was degraded as a function of ICP0 in both cell types. This most likely resulted in the inhibition of DNA repair as inferred by the persistence of gammaH2AX foci or DNA double-strand breaks. Enhanced apoptosis was also found to occur following irradiation of U87-MG cells preinfected with the ICP0-producing HSV-1 mutant, d106. Our results suggest that expression of ICP0 in human glioblastoma multiforme cells inhibits the repair of DNA double-strand breaks after ionizing radiation treatment, decreasing the survival of these cells in part by induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958578     DOI: 10.1158/0008-5472.CAN-04-3793

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

2.  A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Chris Boutell; Sebastien Landry; Junghae Suh; Stephanie Panier; Roger D Everett; Grant S Stewart; Daniel Durocher; Matthew D Weitzman
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

Review 3.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

Review 4.  Chromatin at the intersection of viral infection and DNA damage.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Matthew D Weitzman
Journal:  Biochim Biophys Acta       Date:  2009-07-17

5.  ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression.

Authors:  Masataka Suzuki; Kazue Kasai; Akihiro Ohtsuki; Jakub Godlewski; Michal O Nowicki; E Antonio Chiocca; Yoshinaga Saeki
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

6.  Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.

Authors:  Costas G Hadjipanayis; Wendy Fellows-Mayle; Neal A Deluca
Journal:  Mol Ther       Date:  2008-08-26       Impact factor: 11.454

7.  Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1.

Authors:  S J Advani; J M Markert; R F Sood; S Samuel; G Y Gillespie; M Y Shao; B Roizman; R R Weichselbaum
Journal:  Gene Ther       Date:  2011-05-05       Impact factor: 5.250

Review 8.  The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies.

Authors:  Joshua D Bernstock; Samantha E Hoffman; Jason A Chen; Saksham Gupta; Ari D Kappel; Timothy R Smith; E Antonio Chiocca
Journal:  Viruses       Date:  2021-06-17       Impact factor: 5.048

9.  Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.

Authors:  Gregory K Friedman; Joel Raborn; Virginia M Kelly; Kevin A Cassady; James M Markert; G Yancey Gillespie
Journal:  Front Oncol       Date:  2013-02-28       Impact factor: 6.244

Review 10.  Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy.

Authors:  Jianfang Ning; Hiroaki Wakimoto
Journal:  Front Microbiol       Date:  2014-06-20       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.